Table 3.
Serological analyses of identified clones
| Clone | CTCL
|
Controls
|
||
|---|---|---|---|---|
| Reactive | n | Reactive | n | |
| se1-1 | 50% | 10 | 0% | 5 |
| se2-1 (SCP-1) | 22% | 18 | 0% | 10 |
| se33-2 | 17% | 12 | 20% | 5 |
| (se2-1 homologous) | ||||
| se2-2 | 30% | 10 | 0% | 5 |
| se2-5 | 30% | 10 | 0% | 5 |
| se14-2 (cTAGE-1) | 33% | 18 | 0% | 10 |
| se14-3 | 11% | 9 | 0% | 5 |
| se20-4 | 30% | 10 | 0% | 5 |
| se20-6 | 20% | 10 | 20% | 5 |
| (se20-4 homologous) | ||||
| se20-7 | 30% | 10 | 0% | 5 |
| se20-9 | 22% | 9 | 0% | 5 |
| se20-10 | 11% | 18 | 0% | 10 |
| se33-1 | 29% | 17 | 0% | 10 |
| se37-2 | 29% | 17 | 0% | 10 |
| se57-1 | 33% | 9 | 0% | 5 |
| se70-2 | 13% | 8 | 0% | 5 |
| se89-1 | 71% | 14 | 0% | 5 |
Table gives the percentage of reacting and the total number of tested sera (n) during secondary screening. In the case of clones se2-1 and se20-4, one of the homologous clones is also given, as these differed in their reactivity pattern, which may be due to sequence differences. For details see text.